WO2006067518A3 - Vaccines against neisseria meningitidis - Google Patents
Vaccines against neisseria meningitidis Download PDFInfo
- Publication number
- WO2006067518A3 WO2006067518A3 PCT/GB2005/005113 GB2005005113W WO2006067518A3 WO 2006067518 A3 WO2006067518 A3 WO 2006067518A3 GB 2005005113 W GB2005005113 W GB 2005005113W WO 2006067518 A3 WO2006067518 A3 WO 2006067518A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- neisseria meningitidis
- vaccines against
- against neisseria
- fragment
- variant
- Prior art date
Links
- 229960005486 vaccine Drugs 0.000 title abstract 3
- 241000588650 Neisseria meningitidis Species 0.000 title 1
- 239000012634 fragment Substances 0.000 abstract 3
- 229920001184 polypeptide Polymers 0.000 abstract 3
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 3
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 3
- 230000004927 fusion Effects 0.000 abstract 2
- 125000003275 alpha amino acid group Chemical group 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/22—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Neisseriaceae (F)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Gastroenterology & Hepatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Engineering & Computer Science (AREA)
- Oncology (AREA)
- Immunology (AREA)
- Biochemistry (AREA)
- Inorganic Chemistry (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Priority Applications (16)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2007547670A JP2008525008A (en) | 2004-12-23 | 2005-12-23 | Vaccine against Neisseria meningitidis |
US11/722,690 US20080138357A1 (en) | 2005-12-23 | 2005-12-23 | Vaccines Against Neisseria Meningitidis |
AU2005317835A AU2005317835A1 (en) | 2004-12-23 | 2005-12-23 | Vaccines against Neisseria meningitidis |
MX2007007886A MX2007007886A (en) | 2004-12-23 | 2005-12-23 | Vaccines and their use. |
EP05823115A EP1848457A2 (en) | 2004-12-23 | 2005-12-23 | Vaccines against neisseria meningitidis |
CA002592156A CA2592156A1 (en) | 2004-12-23 | 2005-12-23 | Vaccines against neisseria meningitidis |
AU2006328153A AU2006328153A1 (en) | 2005-12-23 | 2006-12-21 | Neisseria meningitidis vaccines and their use |
KR1020087017965A KR20080090447A (en) | 2005-12-23 | 2006-12-21 | Neisseria meningitidis vaccines and their use |
CA002634911A CA2634911A1 (en) | 2005-12-23 | 2006-12-21 | Neisseria meningitidis vaccines and their use |
JP2008546628A JP2009520491A (en) | 2005-12-23 | 2006-12-21 | Vaccine against Neisseria meningitidis |
EP06831443A EP1976556A2 (en) | 2005-12-23 | 2006-12-21 | Neisseria meningitidis vaccines and their use |
PCT/GB2006/004877 WO2007072032A2 (en) | 2005-12-23 | 2006-12-21 | Neisseria meningitidis vaccines and their use |
US12/158,919 US20090226479A1 (en) | 2005-12-23 | 2006-12-21 | Vaccines and their use |
RU2008130395/13A RU2008130395A (en) | 2005-12-23 | 2006-12-21 | VACCINES AND THEIR APPLICATION |
NO20073256A NO20073256L (en) | 2004-12-23 | 2007-06-25 | Vaccines against meningococcus |
NO20082810A NO20082810L (en) | 2005-12-23 | 2008-06-23 | Vaccine, and use of the same |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBPCT/GB2004/005441 | 2004-12-23 | ||
PCT/GB2004/005441 WO2005060995A2 (en) | 2003-12-23 | 2004-12-23 | Identification of antigenically important neisseria antigens by screening insertional mutant libraries with antiserum |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2006067518A2 WO2006067518A2 (en) | 2006-06-29 |
WO2006067518A3 true WO2006067518A3 (en) | 2006-11-23 |
Family
ID=36282716
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/GB2005/005113 WO2006067518A2 (en) | 2004-12-23 | 2005-12-23 | Vaccines against neisseria meningitidis |
Country Status (10)
Country | Link |
---|---|
EP (1) | EP1848457A2 (en) |
JP (1) | JP2008525008A (en) |
KR (1) | KR20070094762A (en) |
CN (2) | CN101115502A (en) |
AU (1) | AU2005317835A1 (en) |
CA (1) | CA2592156A1 (en) |
MX (1) | MX2007007886A (en) |
NO (1) | NO20073256L (en) |
RU (1) | RU2007127921A (en) |
WO (1) | WO2006067518A2 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2007072032A2 (en) * | 2005-12-23 | 2007-06-28 | Imperial Innovations Limited | Neisseria meningitidis vaccines and their use |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2000003003A2 (en) * | 1998-07-10 | 2000-01-20 | The University Of Nottingham | Screening of neisserial vaccine candidates and vaccines against pathogenic neisseria |
-
2005
- 2005-12-23 KR KR1020077015481A patent/KR20070094762A/en not_active Application Discontinuation
- 2005-12-23 MX MX2007007886A patent/MX2007007886A/en unknown
- 2005-12-23 CA CA002592156A patent/CA2592156A1/en not_active Abandoned
- 2005-12-23 WO PCT/GB2005/005113 patent/WO2006067518A2/en active Application Filing
- 2005-12-23 RU RU2007127921/13A patent/RU2007127921A/en not_active Application Discontinuation
- 2005-12-23 JP JP2007547670A patent/JP2008525008A/en active Pending
- 2005-12-23 AU AU2005317835A patent/AU2005317835A1/en not_active Abandoned
- 2005-12-23 CN CNA2005800479621A patent/CN101115502A/en active Pending
- 2005-12-23 EP EP05823115A patent/EP1848457A2/en not_active Withdrawn
-
2006
- 2006-12-21 CN CNA2006800516894A patent/CN101370514A/en active Pending
-
2007
- 2007-06-25 NO NO20073256A patent/NO20073256L/en not_active Application Discontinuation
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2000003003A2 (en) * | 1998-07-10 | 2000-01-20 | The University Of Nottingham | Screening of neisserial vaccine candidates and vaccines against pathogenic neisseria |
Non-Patent Citations (2)
Title |
---|
KIZIL G ET AL: "IDENTIFICATION AND CHARACTERIZATION OF TSPA, A MAJOR CD4+ T-CELL- AND B-CELL-STIMULATING NEISSERIA-SPECIFIC ANTIGEN", INFECTION AND IMMUNITY, AMERICAN SOCIETY OF MICROBIOLOGY, WASHINGTON, DC, US, vol. 67, no. 7, July 1999 (1999-07-01), pages 3533 - 3541, XP000885437, ISSN: 0019-9567 * |
TETTELIN H ET AL: "COMPLETE GENOME SEQUENCE OF NEISSERIA MENINGTIDIS SEROGROUP B STRAIN MC58", SCIENCE, AMERICAN ASSOCIATION FOR THE ADVANCEMENT OF SCIENCE,, US, vol. 287, 10 March 2000 (2000-03-10), pages 1809 - 1815, XP001019215, ISSN: 0036-8075 * |
Also Published As
Publication number | Publication date |
---|---|
AU2005317835A1 (en) | 2006-06-29 |
NO20073256L (en) | 2007-09-17 |
JP2008525008A (en) | 2008-07-17 |
WO2006067518A2 (en) | 2006-06-29 |
RU2007127921A (en) | 2009-01-27 |
MX2007007886A (en) | 2008-01-16 |
KR20070094762A (en) | 2007-09-21 |
EP1848457A2 (en) | 2007-10-31 |
CN101370514A (en) | 2009-02-18 |
CN101115502A (en) | 2008-01-30 |
CA2592156A1 (en) | 2006-06-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2003515323A5 (en) | ||
BR0010720A (en) | Antigenic neisseria peptides | |
WO1999057280A3 (en) | Neisseria meningitidis antigens and compositions | |
NO20063026L (en) | antibodies | |
WO2006076410A3 (en) | Li-key/antigenic epitope hybrid peptide vaccines | |
WO2007106476A3 (en) | Compositions and methods for enhancing the immunogenicity of antigens | |
WO2009025117A1 (en) | Cdca1 peptide and pharmaceutical agent comprising the same | |
EP2476697A3 (en) | Peptide vaccines for cancers expressing MPHOSPH1 or DEPDC1 polypeptides | |
WO2006131749A3 (en) | Scaffold | |
WO2005011730A8 (en) | Microsome vaccine | |
WO2003031598A3 (en) | Nucleic acid and amino acid sequences encoding high-level expressor factor viii polypeptides and methods of use | |
WO2005028618A3 (en) | Immunogenic compositions for streptococcus agalactiae | |
DK2289533T3 (en) | Epitope peptides derived from carendothelial growth factor receptor-1 as well as vaccines containing these peptides | |
WO2000012535A3 (en) | Neisseria meningitidis polypeptide, nucleic acid sequence and uses thereof | |
WO2005059131A3 (en) | Protein binding miniature proteins and uses thereof | |
WO2006090090A3 (en) | Hiv epitopes and pharmaceutical composition containing same | |
ZA200006309B (en) | A polypeptide comprising the amino acid of an n-terminal choline binding protein a truncate, vaccine derived therefrom and uses thereof. | |
MY144766A (en) | Plant virus coat fusion proteins with gdf8 epitopes and vaccines thereof | |
DE602004028266D1 (en) | ANGIOGENIC PEPTIDES AND ITS USES | |
DK1913020T3 (en) | Immunogenic constructs | |
WO2006067518A3 (en) | Vaccines against neisseria meningitidis | |
WO2003083124A3 (en) | Peptide epitopes common to antigens of the same multigene family | |
WO2007072032A3 (en) | Neisseria meningitidis vaccines and their use | |
WO2006027584A3 (en) | Vaccines against neisseria | |
WO2007127372A3 (en) | Genetic adjuvants for viral vaccines |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KM KN KP KR KZ LC LK LR LS LT LU LV LY MA MD MG MK MN MW MX MZ NA NG NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SM SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU LV MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2007547670 Country of ref document: JP Ref document number: 2592156 Country of ref document: CA Ref document number: 11722690 Country of ref document: US |
|
WWE | Wipo information: entry into national phase |
Ref document number: 556101 Country of ref document: NZ Ref document number: MX/a/2007/007886 Country of ref document: MX |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2005317835 Country of ref document: AU |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1020077015481 Country of ref document: KR |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2005823115 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 5528/DELNP/2007 Country of ref document: IN |
|
ENP | Entry into the national phase |
Ref document number: 2005317835 Country of ref document: AU Date of ref document: 20051223 Kind code of ref document: A |
|
WWP | Wipo information: published in national office |
Ref document number: 2005317835 Country of ref document: AU |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2007127921 Country of ref document: RU |
|
WWE | Wipo information: entry into national phase |
Ref document number: 200580047962.1 Country of ref document: CN |
|
WWP | Wipo information: published in national office |
Ref document number: 2005823115 Country of ref document: EP |